Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Open accessThe DOI matches its Crossref record; 235 of the 239 references it cites were found in a registry or an index.
Abstract
These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT). Although there are many reassuring retrospective studies on the efficacy and safety of OPAT, few prospective studies have been conducted to compare the risks and outcomes for patients who receive treatment as outpatients rather than as inpatients. Because truly evidence-based studies are lacking, the present guidelines are formulated from the collective experience of the committee members and advisors from related organizations. Important aspects of OPAT are described in the text and tables and include the following: The literature supports the effectiveness of OPAT for a wide variety of infections (table 1 and the Appendix). Infections treated with outpatient parenteral antimicrobial therapy (OPAT) and the antibiotics used in 4 studies or sites. A thorough assessment of the patient's general medical condition, the infectious process, and the home situation is necessary before starting therapy (table 2) Specific considerations in evaluating patients for outpatient parenteral antimicrobial therapy (OPAT). Prescribing physicians should be aware of a number of aspects of OPAT which distinguish it from other forms of therapy. These include the required teamwork, communication, monitoring, and outcome measurements (tables 3 and 4). Key elements required for an outpatient parenteral antimicrobial therapy (OPAT) program. Key elements required for evaluating an outpatient parenteral antimicrobial therapy (OPAT) program when the patient is to be referred. The physician has a unique role on the OPAT team, which may also include nursing, pharmacy, and social services. These responsibilities include establishing a diagnosis, prescribing treatment, determining the appropriate site of care, monitoring during therapy, and assuring the overall quality of care. Antimicrobial selection for OPAT is different from that for therapy in the hospital. Once-daily drug administration has many advantages. Potential for adverse effects and the stability of an antimicrobial once it is mixed must be considered (tables 5–7). Properties of commonly prescribed antimicrobials at various temperatures. Suggestions for laboratory parameters that should be monitored weekly during outpatient parenteral antimicrobial therapy (OPAT). The importance of administering the first dose of an antibiotic in a supervised setting is emphasized. Regular clinical and laboratory monitoring of patients receiving OPAT is essential and varies with the antimicrobial chosen (table 8). Outcome measures for outpatient parenteral antimicrobial therapy (OPAT). Outcomes measures should be an integral part of any OPAT program, to assure the effectiveness and quality of care (table 9). Internet resources with information on outpatient parenteral antimicrobial therapy (OPAT). Children receiving OPAT must be considered differently because of their special needs. The practice of administering intravenous antimicrobial therapy in the home and in alternate care settings has grown rapidly since it was first described in 1974 by Rucker and Harrison [1]. The most common infections treated and antimicrobials used by a variety of programs are shown in table 1. In the United States, OPAT is estimated to be a multibillion-dollar-a-year industry and is provided to 1 in 1000 Americans each year [10]. The growth of OPAT has been fueled by a variety of factors including the push for cost containment, the development of antimicrobial agents that can be administered once daily, technological advances in vascular access and infusion devices, increased acceptance of such therapy by both patients and health care personnel, and the availability of reliable and skilled services for OPAT in the community. Although OPAT has become widely accepted as a form of medical therapy (see Appendix), more information is needed regarding its benefits, safety, and limitations. This is especially true with the economic incentives for early discharge that exist for payors. These guidelines update those written in 1997 [11] and are intended to ensure successful implementation of parenteral antimicrobial services for patients in varied community settings, including the home and outpatient facilities, such as physicians' offices, hospital clinics, ambulatory-care centers, day hospitals, and skilled nursing facilities. They have been formulated to incorporate the perspectives of the team of physicians, nurses, pharmacists and other health care professionals necessary for an effective and safe program [6, 8, 12]. Advice and participation were requested of the leading infusion-nurse, pharmacy, and to a on the The were formulated from the collective clinical experience of the of and from the organizations. In the of the and quality of in of OPAT is by a of prospective studies and a number of are The information can a for programs to
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Kaushal, R. (2001) · JAMA · doi:10.1001/jama.285.16.2114 · Cited by 1,917
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Guidelines for the prevention of intravascular catheter-related infections
da Silva, G. D., de Almeida, V. S., Querido, D. L., Esteves, A. P. V. D. S., dos Santos, J. P. O., & Rezende, T. F. (2012) · doi:10.5205/3705 · Cited by 1,119
Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A., Marrie, T. J., Sarosi, G. A., Torres, A., & Yu, V. L. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1418 · Cited by 1,045
(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Quality of Care, Process, and Outcomes in Elderly Patients With Pneumonia
Meehan, T. P. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550230056037 · Cited by 919
Research works printed but not linked: 28
- Winters, 1992, Home infusion therapy: a service and demographic profile: a report for the National Alliance for Infusion Therapy, 1
- Hankwitz, 1994, The expanding and increasingly important role of the home health care agency medical director, Am Ac Home Care Phys Newsletter, 6, 8
- Tice, 1993, Growing pains in outpatient intravenous antibiotic therapy, Infect Dis Clin Pract, 1, 74
- 1986, Wickline v State of California, 228 Cal. Rptr. 661, 192. Cap. App. 3d 1630
- 1981, Physicians, surgeons and other healers. American Jurisprudence, 226
- Tice, 1997, Delivery models for outpatient parenteral antimicrobial therapy. In: Outpatient parenteral antimicrobial therapy: current status, 7
- Residency Review Committee, Specific program content. CAAR Program Information from Workshop for Internal Medicine Subspecialty Residencies in Infectious Disease. 11. 2001. American Board of Internal Medicine. Ref Type: Conference Proceeding.
- Lonsway, 2001, Intravenous therapy in the home, 501
- Mortlock, 2001, Intravenous therapy in the alternative care setting, 535
- Skokal, 2000, IV push at home?, RN, 63, 26
- Tice, 2002, Adverse effects with intravenous antibiotics with OPAT
- Rehm, 2000, Rates of adverse events associated with community-based parenteral anti-infective therapy, J Clin Outcomes Manage, 7, 23
- Martinelli, 1988, Aminoglycoside questionnaire results
- Hautekeete, 1995, Hepatotoxicity of antibitoics, Acta Gastroenterol Belg, 58, 290
- 1999, 2000–2001 Comprehensive accreditation manual for ambulatory care
- Barrell, 1998, ORYX: outcomes measurement and accreditation, Infusion, May, 37
- Poole, 1998, Outcomes measurements: making sense of the data, Infusion, May, 25
- Tice, 2000, Documenting the value of OPAT: outcomes studies and patient registries, Can J Infect Dis, 10, 45
- Tice, 2000, Outcomes registry for outpatient IV antimicrobial therapy, Infusion, May, 27
- Outpatient Parenteral Antimicrobial Therpay Outcomes Registry Web site
- Tice, 2003, Reasons for failures with OPAT [abstract 293]
- Arditi, 1990, Convalescent outpatient therapy for selected children with acute bacterial meningitis, Semin Pediatr Infect Dis, 1, 404
- Sudela, 1990, Nursing aspects of pediatric home infusion therapy for the treatment of serious, Semin Pediatr Infect Dis, 1, 306
- Tice, 2003, OPAT outcomes registry evaluaton of diabetic extremity infections [abstract 291]
- Wai, 1999, A cost analysis of an outpatient parenteral antibiotic program (OPAT): a Canadian teaching hospital and ministry of health perspective, 133
- Tice, 1997, Osteomyelitis
- Rehm, 1992, Home intravenous antibiotic therapy (HIVAT) for endocarditis
- Gentry, 1989, New approches to the diagnosis and treatment of infective endocarditis, Texas Heart Institute J, 16, 250
Cited by
Items 501–575 of 575
Outpatient Parenteral Antimicrobial Therapy (OPAT)
Baum, S. G. (2004) · Journal watch · doi:10.1056/id200407260000012 · Cited by 1
Keller, S. C., Hsu, Y., & Cosgrove, S. E. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy110 · Cited by 1
Bugeja, S. J. (2020) · Open Access Institutional Repository at Robert Gordon University (Robert Gordon University) · doi:10.48526/rgu-wt-1357920 · Cited by 1
Mujal, A., & de Medicina, U. A. D. B. D. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Infective Endocarditis, Device Infections, and Cardiac Manifestations of HIV
Hyle, E. P., Hurtado, R. M., & Gandhi, R. T. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4483-0_29
COL·LOQUI HOSPITALITZACIÓ A DOMICILI: Maneig de les malalties infeccioses.
Estrada, O. (2006) · Revista de la Reial Acadèmia de Medicina de Catalunya
Daptomycin for Treatment of Complicated Skin and Skin Structure Infections
Le, M. J. A. J. (2012) · Healthy Aging & Clinical Care in the Elderly · doi:10.4137/hacce.s7655
Tratamiento de las neumonías extrahospitalarias y hospitalización a domicilio
Estrada, O., Bonet, G., Riera, C. M., & Cuxart, A. (2005) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13071617
Pharmacist interventions throughout care transitions: a review of current practices
Testman, J. A., Teichman, A., Cook, S. J., Kimble, A. M., Riley, B. L., Robinson, J., & Snodgrass, B. (2013) · International Current Pharmaceutical Journal · doi:10.3329/icpj.v2i10.16409
Gardner, J., Dougherty, J., Timko, D. R., Binkley, S., Morgan, S., Cluzet, V. C., Pegues, D. A., & Hamilton, K. W. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv133.1018
Dental approach in patients with bacterial endocarditis risk.
Todea, C. D., Ionac, A., Miron, M. I., Hanigovski, E., & Filip, L. M. (2010)
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
Bucher, A. (2005) · NORA - Norwegian Open Research Archives
Outpatient Parenteral Antibiotic Therapy and the Diabetic Foot
Chua, A., & Fisher, D. A. (2008) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812791535_0018
Campuzano, M. R. (2016) · Digitum: Institutional Repository of the University of Murcia (University of Murcia)
L’accessibilité de la thérapie intraveineuse à domicile pour les enfants et adolescents canadiens
Moore, D., & Bortolussi, R. A. (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.2.110
Estrada, O. (2006) · Revista de la Reial Acadèmia de Medicina de Catalunya
Home intravenous antibiotic therapy – Preliminary experience of a pulmonology department
Meira, L., Almeida, L. M., Pereira, A., Damas, C., & Amorim, A. A. (2018) · Pulmonology · doi:10.1016/j.pulmoe.2018.04.001
Non-Purulent Skin and Soft Tissue Infections in the Emergency Department
Yadav, K. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-22024
Liu, S. T. H., Bailey, M. J., Zheng, A., Saunders-Hao, P., Bassily‐Marcus, A., Harding, M., Rana, M. M., Kohli-Seth, R. D., Patel, G., Huprikar, S. S., et al. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.220
Outpatient Intravenous Antibiotic Therapy: Reduces economic burden of patients
Mohammed, A., QADRIE, Z. L., Nagavamsidhar, M., Suman, A., Saiteja, D., & Shivani, P. (2018) · Pharmatutor · doi:10.29161/pt.v6.i9.2018.24
The collaboration compass: Using grounded theory to map interactive navigation
Turnbull, L. (2017) · Northumbria Research Link (Northumbria University)
Bhavan, K., Ganguly, A., & Agrawal, D. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy210.1599
Zhou, Y. (2018) · ResearchWorks at the University of Washington (University of Washington)
IV vs. Oral Antibiotics for Treatment of Infective Endocarditis Associated with IV Drug Use
Locke, C. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/rgss-rj37
Infección de prótesis articular en el paciente anciano
González, B. A. (2018) · UCrea (University of Cantabria)
D’Couto, H. T. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Evaluation of an Outpatient Parenteral Antimicrobial Therapy Program in a Specialty Clinic Setting
Hauk, E. (2019) · Digital Commons @ Butler University (Butler University)
Moenster, R. P. (2018) · Journal of Infectious Diseases & Travel Medicine · doi:10.23880/jidtm-16000122
Non-inpatient parenteral antimicrobial therapy
Nathwani, D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00133-7
Community, Ambulatory Care, and Home Care Pharmacy Practice
Stensland, S. L., & Bertch, K. E. (2019) · ASHP eBooks · doi:10.37573/9781585285020.004
Ibrahim, L. F. (2019) · Minerva Access (University of Melbourne)
Hayden, M. C. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
OUTPATIENT INTRAVENOUS ANTIMICROBIAL THERAPY FOR SERIOUS INFECTIONS
Bradley, J. S. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50255-7
Self-citationKumar, S., Manghani, C., & Nersisson, R. (2021) · International Conference on Intelligent Technologies (CONIT) · doi:10.1109/conit51480.2021.9498337
Endocardite infeciosa - abordagem clinica, tratamento e prognóstico
Gonçalves, J. P. B. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/hxd2-k851
Postoperative Management of Periprosthetic Joint Infection
Hu, C., Belden, K. A., & Silibovsky, R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7928-4_20
Thomas, Z., & McCoy, D. (2011) · Springer eBooks · doi:10.1007/978-0-85729-606-1_6
Alexander, M. (2004) · Journal of Infusion Nursing · doi:10.1097/00129804-200409000-00001
(2021) · Revista Española de Quimioterapia · doi:10.37201/202103
Clinical Controversies in Outpatient Parenteral Antimicrobial Therapy (OPAT)
Keller, S. C., Perhac, A., & Brenon, J. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-98427-4_34
A Multidisciplinary Approach to Outpatient Parenteral Antimicrobial Therapy Care
Curbelo-Irizarry, A. (2023) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001254
Akılcı İlaç Kullanımı ve Klinik Farmakoloji
Singirik, E., Kaplan, H. M., Kahraman, İ., Arslan, S., El, Ç., Çelik, E., Çelik, M. M., Karapınar, O. S., Turgut, F. H., Yetim, İ., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1465
Derosais, B., Couturaud, A., Fiaux, E., Zeggay, A., Sabatier, T., Soubieux, A., Dujardin, F. H., & Curado, J. (2024) · Infectious Diseases Now · doi:10.1016/j.idnow.2024.104976
Assessment for Catheter Function, Dressing Adherence, and Device Necessity
Weston, V. (2024) · Springer eBooks · doi:10.1007/978-3-031-48576-3_30
Infectious diseases today – more questions than answers?
Tonna, I. (2009) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/1478271520093904030
Čivljak, R., & Mihanović, M. P. (2024) · Clinical gastroenterology · doi:10.1007/978-3-031-69800-2_19
Outpatient Intravenous Antimicrobial Therapy for Serious Infections
Pong, A. L., & Bradley, J. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00254-5
Self-citationJiang, L., Lin, Z., Wu, S., & Chen, T. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1539372
Burnet, E., Bras, A. L., Roucoux, G., Dupont, C., Canouï, É., Leclaire, C., Zerbit, J., Burgel, P., Martin, C., Durand‐Zaleski, I., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14100971
Anti-Microbial Utilization in Surgical Wards: A Systematic Review
Tamil Selvan, M., Lavanya, K., Nileshraj, G., & Jayanthi, M. K. (2023) · International Journal of Pharmaceutical and Clinical Research · doi:10.5281/zenodo.12636937
Águas não Tratadas no Norte de Portugal. Qualidade Microbiológica e Resistência aos Antibióticos
Freire, T. A. D. S. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/cvvn-tv13
Howe, Z. (2019) · Digital Commons @ Butler University (Butler University)
Gilszlak Kornhauser, E., de Medicina, U. A. D. B. D., & de Medicina, U. A. D. B. F. (2013) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
Berrevoets, M. A. H. (2021) · Radboud Repository (Radboud University)
Reigosa, B. A. (2025) · Biblos-e Archivo (Universidad Autónoma de Madrid)
National acute medicine programme report 2010
Royal College of Physicians of Ireland, Irish Association of Directors of Nursing and Midwifery, Therapy Professions Committee, & Health Service Executive, Q. A. C. C. D. (2011) · Lenus, The Irish Health Repository (Dr Steevens Hospital Library)
Ganguly, A. P. (2018) · Digital Commons-TMC (Texas Medical Center)
Juaton, M. (2020) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Vivero Larraza, A. (2025) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Актуальные аспекты лечения гематогенного остеомиелита у детей: обзор литературы
Назаров, Н. Н. (2026) · Central Asian Journal of Multidisciplinary Research and Management Studies · doi:10.70413/cajmrms-v03-i01-s47736
Elshaib, L. A. (2021) · Research in Pediatrics & Neonatology · doi:10.31031/rpn.2021.05.000625
Ethical Considerations in the Use of Indwelling Lines in Persons Who Use Injection Drugs
Green, A. S., Feldman, W. B., & Solomon, D. A. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag109
Seak, C., Goh, Z. N. L., & Cheng, H.-T. (2026) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2026.08.027
Outpatient Parenteral Antimicrobial Therapy Practice Variability Across Veterans Affairs Hospitals
Scruggs-Wodkowski, E. A., Gauntlett, L., Helminski, D., Blok, A. C., Henry, N., Keller, S. C., Kendall, R. E., Nitta, M., Ranusch, A., Manojlovich, M., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.29952
Broadhurst, D. A. (2020) · AUSpace (Athabasca University)
Finding a stable formulation for cloxacillin infusion
Vakkila, R. (2025) · UEF eRepo (University of Eastern Finland)
Thomnoi, T., & Santimaleeworagun, W. (2021) · Thai Phai Satchayaniphon · doi:10.69598/tbps.16.2.19-31
Outpatient parenteral antimicrobial therapy (OPAT) guidelines: A systematic review
Lim, A. H., Rahman, N. A., Nor, A. N. M., & Misnan, N. A. (2026) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2026.09.015
Nuzzolo-Shihadeh, L., Mata-Cruz, L., Hernández-Guedea, M. A., Bocanegra‐Ibarias, P., & Camacho-Ortíz, A. (2026) · IJID Regions · doi:10.1016/j.ijregi.2026.101053
Metadata
- Authors
- Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Rady Children's Hospital-San Diego (US)
- Consultants in Infectious Diseases, Lubbock, Texas
- Springfield Clinic (US)
- Morgantown Internal Medicine Group, Morgantown, West Virginia
- Pfizer (United States) (US)
- Florida Infection Physicians, Gainsville
- Hennepin County Medical Center (US)
- Corresponding author
- Tice, Alan D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-15
- Volume
- 38
- Issue
- 12
- Pages
- 1651-1671
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141994303
- Cited by
- 532
- References
- 239
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 18 · 2023: 17 · 2022: 21 · 2021: 21 · 2020: 31 · 2019: 38 · 2018: 48 · 2017: 40 · 2016: 43 · 2015: 32 · 2014: 36 · 2013: 31 · 2012: 21
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- outpatient parenteral antimicrobial therapy, outpatient antibiotic therapy, patient selection, antimicrobial selection, once-daily dosing, drug stability, laboratory monitoring, adverse drug reactions, quality of care, multidisciplinary team
- MeSH terms
- Adult, Anti-Bacterial Agents, Child, Home Care Services, Humans, Infusions, Intravenous, Outpatients, Patient Care Team, Pediatrics, Drug Monitoring, Outcome Assessment, Health Care, Patient Selection, Home Infusion Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.